Real-time PCR demonstrated that other markers of the brain lymphatic vessels including LYVE-1, Prox1, PDPN, and VEGF-R3 were significantly increased in the control AD model compared to the normal group (p < 0.001, Figures 6(a)–6(d)). This evidence concerns the gene LYVE1 and Alzheimer disease.